Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Micholle v. Ophthotech Corporation et al
Case Number:
1:17-cv-00210
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
- Gainey McKenna
- Glancy Prongay
- Levi & Korsinsky
- Motley Rice
- Pomerantz LLP
- Robbins Geller
- WilmerHale
- Wolf Popper
Companies
Sectors & Industries:
-
September 13, 2021
Retina Drug Co. Settles Investor Row For $29M
Investors in Ophthotech Corp. asked a New York federal judge Friday to approve a $29 million cash settlement they had reached with the biopharmaceutical company over claims that it misled shareholders regarding clinical trial phases for a macular degeneration drug.
-
September 18, 2019
Retina Drug Co. Can't End Claims It Misled Investors
Biopharmaceutical company Ophthotech Corp. must face some, but not all, claims that it misled investors regarding clinical trial phases for a macular degeneration drug, a New York federal judge ruled Wednesday.